Assesmentt of the efficacy of antiemetics for post procedure sedation vomiting (PPSV) in ED pediatric patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000370

Enrollment

270

Registered

2012-02-29

Start date

2010-10-14

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Control group: Ketamine 4mg/kg, 1 dose, Intramuscular(IM) Experimental group 1: Ketamine 4mg/kg, 1 dose, IM + metoclopramide 0.4mg/kg, 1 dose, IM co-administration Experimental group 2: Ketamin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients between 4 months and 5 years of age who were American Society of Anesthesiologists I or II(15) who received intramuscular (IM) ketamine for laceration repair.

Exclusion criteria

Exclusion criteria: patients with a concurrent vomiting illness; those with a previous adverse reaction to ketamine, atropine or metoclopramide; those with parents unwilling to provide informed consent; those with contraindications for trial drugs; and those who not sedated after first dose of IM ketamine.

Design outcomes

Primary

Measure	Time frame
a measure of the incidence rate of KAV according adjunctive drugs in the ED and after discharge.	—

Secondary

Measure	Time frame
the time of normal diet after ketamine sedation.	—

Countries

Korea, Republic of

Contacts

Public ContactJi-sook Lee

Ajou University

Outcome results